Open Access

[Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma

  • Authors:
    • Peng Zhou
    • Xuemin Li
  • View Affiliations

  • Published online on: March 19, 2024     https://doi.org/10.3892/ol.2024.14347
  • Article Number: 215
  • Copyright : © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

May-2024
Volume 27 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou P and Zhou P: [Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma. Oncol Lett 27: 215, 2024
APA
Zhou, P., & Zhou, P. (2024). [Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma. Oncology Letters, 27, 215. https://doi.org/10.3892/ol.2024.14347
MLA
Zhou, P., Li, X."[Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma". Oncology Letters 27.5 (2024): 215.
Chicago
Zhou, P., Li, X."[Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma". Oncology Letters 27, no. 5 (2024): 215. https://doi.org/10.3892/ol.2024.14347